Pleiotropic actions of ticagrelor versus clopidogrel – Do molecular differences translate into superior clinical efficacy after myocardial infarction?
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-04-01
|
Series: | International Journal of Cardiology: Heart & Vasculature |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352906720300737 |
id |
doaj-da74db641d764420a4262042916c564b |
---|---|
record_format |
Article |
spelling |
doaj-da74db641d764420a4262042916c564b2020-11-25T02:51:08ZengElsevierInternational Journal of Cardiology: Heart & Vasculature2352-90672020-04-0127Pleiotropic actions of ticagrelor versus clopidogrel – Do molecular differences translate into superior clinical efficacy after myocardial infarction?Anke C. Fender0Dobromir Dobrev1Corresponding author at: Institute of Pharmacology, Medical Faculty, University Duisburg-Essen, Hufelandstr. 55, 45122 Essen, Germany.; Institute of Pharmacology, Medical Faculty, University Duisburg-Essen, GermanyInstitute of Pharmacology, Medical Faculty, University Duisburg-Essen, Germanyhttp://www.sciencedirect.com/science/article/pii/S2352906720300737TicagrelorClopidogrelP2Y12BleedingMyocardial infarction |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Anke C. Fender Dobromir Dobrev |
spellingShingle |
Anke C. Fender Dobromir Dobrev Pleiotropic actions of ticagrelor versus clopidogrel – Do molecular differences translate into superior clinical efficacy after myocardial infarction? International Journal of Cardiology: Heart & Vasculature Ticagrelor Clopidogrel P2Y12 Bleeding Myocardial infarction |
author_facet |
Anke C. Fender Dobromir Dobrev |
author_sort |
Anke C. Fender |
title |
Pleiotropic actions of ticagrelor versus clopidogrel – Do molecular differences translate into superior clinical efficacy after myocardial infarction? |
title_short |
Pleiotropic actions of ticagrelor versus clopidogrel – Do molecular differences translate into superior clinical efficacy after myocardial infarction? |
title_full |
Pleiotropic actions of ticagrelor versus clopidogrel – Do molecular differences translate into superior clinical efficacy after myocardial infarction? |
title_fullStr |
Pleiotropic actions of ticagrelor versus clopidogrel – Do molecular differences translate into superior clinical efficacy after myocardial infarction? |
title_full_unstemmed |
Pleiotropic actions of ticagrelor versus clopidogrel – Do molecular differences translate into superior clinical efficacy after myocardial infarction? |
title_sort |
pleiotropic actions of ticagrelor versus clopidogrel – do molecular differences translate into superior clinical efficacy after myocardial infarction? |
publisher |
Elsevier |
series |
International Journal of Cardiology: Heart & Vasculature |
issn |
2352-9067 |
publishDate |
2020-04-01 |
topic |
Ticagrelor Clopidogrel P2Y12 Bleeding Myocardial infarction |
url |
http://www.sciencedirect.com/science/article/pii/S2352906720300737 |
work_keys_str_mv |
AT ankecfender pleiotropicactionsofticagrelorversusclopidogreldomoleculardifferencestranslateintosuperiorclinicalefficacyaftermyocardialinfarction AT dobromirdobrev pleiotropicactionsofticagrelorversusclopidogreldomoleculardifferencestranslateintosuperiorclinicalefficacyaftermyocardialinfarction |
_version_ |
1724736110063517696 |